Ten Cancer Research UK Scientists Become EMBO Elect

Main Category: Cancer / Oncology
Article Date: 06 Nov 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Ten Cancer Research UK funded scientists have been elected to the European Molecular Biology Organization (EMBO) - a prestigious body which recognises and promotes talented scientists in the molecular life sciences field.

These experts are among 66 leading life scientists who have been awarded membership of EMBO this year. They join a select group of 1,420 of the world's most prominent molecular biologists from a cross-section of fields, including evolutionary and computational biology, neuroscience and plant science.

EMBO members contribute their expertise to a range of activities, including mentoring young scientists, serving on committees and nominating new members. EMBO is also known for its peer-reviewed journals - the EMBO Journal, EMBO reports, Molecular Systems Biology and EMBO Molecular Medicine.

One of the ten elected, Dr Simon Boulton , head of Cancer Research UK's DNA damage response laboratory at its London Research Institute, said: "I am greatly honoured by this election - it recognises our cutting edge science for the charity. My lab focuses on understanding the molecular basis of genome instability disorders, which predispose us to cancer. We are attempting to define how DNA damage is sensed and repaired in cells and how a process called homologous recombination, which promotes accurate repair of DNA lesions, is regulated during these critical cellular events.

The ten Cancer Research UK funded scientists elected this year are:

- Dr Julia Cooper, Cancer Research UK's London Research Institute
- Dr Facundo Batista, Cancer Research UK's London Research Institute
- Dr Simon Boulton, Cancer Research UK's London Research Institute
- Professor Mike Stratton, The Institute of Cancer Research, London
- Professor Richard Marais, The Institute of Cancer Research, London
- Professor Iain Hagan, Paterson Institute for Cancer Research, Manchester
- Professor Francis Barr, Cancer Research Centre, University of Liverpool
- Professor Ronald Hay, University of St Andrews
- Professor Margaret Frame, Cancer Research UK's Edinburgh Cancer Centre
- Professor Robert White, Cancer Research UK's Beatson Institute for Cancer Research, Glasgow

Dr David Scott, director of science funding at Cancer Research UK said: "We are very proud so many scientists funded by Cancer Research UK have been given this prestigious award. Membership of this distinguished scientific organisation recognises their innovative research, and the hard work of their colleagues, that is helping us to better understand more about the causes of cancer."

Source
Cancer Research UK

Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cancer Research UK. "Ten Cancer Research UK Scientists Become EMBO Elect." Medical News Today. MediLexicon, Intl., 6 Nov. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/170103.php>

APA
Cancer Research UK. (2009, November 6). "Ten Cancer Research UK Scientists Become EMBO Elect." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/170103.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »